These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22733603)

  • 21. Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following "bath salts" injection.
    Sutamtewagul G; Sood V; Nugent K
    Clin Nephrol; 2014 Jan; 81(1):63-6. PubMed ID: 24356039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature.
    Kesha K; Boggs CL; Ripple MG; Allan CH; Levine B; Jufer-Phipps R; Doyon S; Chi P; Fowler DR
    J Forensic Sci; 2013 Nov; 58(6):1654-9. PubMed ID: 23822613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current "legal highs".
    Johnson LA; Johnson RL; Portier RB
    J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of edible marijuana product exposures reported to United States poison centers.
    Cao D; Srisuma S; Bronstein AC; Hoyte CO
    Clin Toxicol (Phila); 2016 Nov; 54(9):840-846. PubMed ID: 27418198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.
    Gunderson EW; Kirkpatrick MG; Willing LM; Holstege CP
    J Addict Med; 2013; 7(3):153-62. PubMed ID: 23732954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW; Brooks DE
    J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
    Seely KA; Patton AL; Moran CL; Womack ML; Prather PL; Fantegrossi WE; Radominska-Pandya A; Endres GW; Channell KB; Smith NH; McCain KR; James LP; Moran JH
    Forensic Sci Int; 2013 Dec; 233(1-3):416-22. PubMed ID: 24314548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bath salt abuse: more than just hot water.
    Terry SM
    J Emerg Nurs; 2014 Jan; 40(1):88-91. PubMed ID: 23927860
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute psychosis induced by bath salts: a case report with clinical and forensic implications.
    Stoica MV; Felthous AR
    J Forensic Sci; 2013 Mar; 58(2):530-3. PubMed ID: 23317451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report.
    Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Dart RC
    Clin Toxicol (Phila); 2011 Dec; 49(10):910-41. PubMed ID: 22165864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic cathinones in Southern Germany - characteristics of users, substance-patterns, co-ingestions, and complications.
    Romanek K; Stenzel J; Schmoll S; Schrettl V; Geith S; Eyer F; Rabe C
    Clin Toxicol (Phila); 2017 Jul; 55(6):573-578. PubMed ID: 28347165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Methylenedioxypyrovalerone Toxicity.
    Froberg BA; Levine M; Beuhler MC; Judge BS; Moore PW; Engebretsen KM; Mckeown NJ; Rosenbaum CD; Young AC; Rusyniak DE;
    J Med Toxicol; 2015 Jun; 11(2):185-94. PubMed ID: 25468313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cristalius: a case in designer drugs.
    Lenz J; Brown J; Flagg S; Oh R; Batts K; Ditzler T; Johnson J
    Mil Med; 2013 Jul; 178(7):e893-5. PubMed ID: 23820374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.
    Thornton SL; Gerona RR; Tomaszewski CA
    J Med Toxicol; 2012 Sep; 8(3):310-3. PubMed ID: 22528592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
    German CL; Fleckenstein AE; Hanson GR
    Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017.
    Carpenter JE; Murray BP; Dunkley C; Kazzi ZN; Gittinger MH
    Clin Toxicol (Phila); 2019 Apr; 57(4):282-286. PubMed ID: 30430874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.